Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Daiichi Sankyo
Argus Health
Fish and Richardson
Federal Trade Commission
Boehringer Ingelheim

Generated: February 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 078454

« Back to Dashboard

NDA 078454 describes MOEXIPRIL HYDROCHLORIDE, which is a drug marketed by Apotex Inc, Chartwell Rx, Glenmark Generics, Teva, Glenmark Pharms, and Heritage Pharms Inc, and is included in eight NDAs. It is available from six suppliers. Additional details are available on the MOEXIPRIL HYDROCHLORIDE profile page.

The generic ingredient in MOEXIPRIL HYDROCHLORIDE is hydrochlorothiazide; moexipril hydrochloride. There are thirty-one drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; moexipril hydrochloride profile page.
Summary for 078454
Applicant:Apotex Inc
Ingredient:moexipril hydrochloride
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 078454
Suppliers and Packaging for NDA: 078454
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 078454 ANDA Physicians Total Care, Inc. 54868-4883 E 54868-4883-0
MOEXIPRIL HYDROCHLORIDE moexipril hydrochloride TABLET;ORAL 078454 ANDA Physicians Total Care, Inc. 54868-4883 E 54868-4883-1

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength7.5MG
Approval Date:Jun 2, 2008TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength15MG
Approval Date:Jun 2, 2008TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
US Army
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.